Welcome to our dedicated page for Vector Acquisition Ii news (Ticker: VAQC), a resource for investors and traders seeking the latest updates and insights on Vector Acquisition Ii stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Vector Acquisition Ii's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Vector Acquisition Ii's position in the market.
Vector Acquisition Corporation II has successfully closed its upsized initial public offering (IPO) of 45 million Class A ordinary shares priced at $10.00 per share, raising gross proceeds of $450 million. The shares began trading on the Nasdaq under the ticker symbol VAQC on March 10, 2021. Deutsche Bank Securities and BofA Securities led the offering as joint book-running managers. Additionally, the underwriters have a 45-day option to purchase up to 6.75 million extra shares to cover over-allotments. This IPO aids the company in pursuing its acquisition goals.
Vector Acquisition Corporation II has announced the pricing of its upsized IPO, offering 45 million Class A ordinary shares at $10.00 each. The shares will be traded on the Nasdaq under the ticker symbol VAQC, with Deutsche Bank and BofA Securities acting as joint book-running managers. There is an option for underwriters to purchase an additional 6.75 million shares to cover over-allotments. The offering is scheduled to close on March 12, 2021, subject to customary conditions. The registration statement became effective on March 9, 2021.